Evotec SE (EVO) Income towards Parent Company (2009 - 2025)
Evotec SE's (EVO) quarterly Income towards Parent Company came in at -$33.3 million in Q4 2025, up 60.83% year-over-year from -$20.7 million in Q4 2024, and up 33.56% quarter-over-quarter from -$50.1 million in Q3 2025.
Analysis
Evotec SE (EVO) Income towards Parent Company (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Income towards Parent Company across 9 years of filings, most recently posting -$33.3 million for Q4 2025.
- In Q4 2025, Income towards Parent Company rose 60.83% year-over-year to -$33.3 million; the TTM figure through Dec 2025 stood at -$144.4 million (up 50.69% YoY), while the FY2025 annual figure was -$79.1 million, up 61.91% from the prior year.
- Income towards Parent Company came in at -$33.3 million for Q4 2025 at Evotec SE, up from -$50.1 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $158.3 million in Q3 2021 to a low of -$112.6 million in Q2 2024.
- Average Income towards Parent Company over 5 years is -$14.7 million, with a median of -$32.4 million recorded in 2025.
- The largest YoY upside for Income towards Parent Company was 9714.16% in 2021 against a maximum downside of 7140.17% in 2021.
- Over 5 years, Income towards Parent Company stood at -$36.0 million in 2021, then jumped by 177.07% to $27.8 million in 2022, then tumbled by 223.75% to -$34.3 million in 2023, then sank by 147.3% to -$84.9 million in 2024, then surged by 60.83% to -$33.3 million in 2025.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$33.3 million in Q4 2025, -$50.1 million in Q3 2025, and -$31.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -33.27 Mn |
| Sep 30, 2025 | -50.07 Mn |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -29.58 Mn |
| Dec 31, 2024 | -84.93 Mn |
| Sep 30, 2024 | -59.43 Mn |
| Jun 30, 2024 | -112.65 Mn |
| Mar 31, 2024 | -35.73 Mn |
| Dec 31, 2023 | -34.34 Mn |
| Jun 30, 2023 | -13.89 Mn |
| Dec 31, 2022 | 27.75 Mn |
| Sep 30, 2022 | 47.67 Mn |
| Jun 30, 2022 | -29.81 Mn |
| Mar 31, 2022 | -82.20 Mn |
| Dec 31, 2021 | -36.01 Mn |
| Sep 30, 2021 | 158.34 Mn |
| Jun 30, 2021 | 72.27 Mn |
| Mar 31, 2021 | 63.57 Mn |
| Dec 31, 2020 | 511,492.35 |
| Sep 30, 2020 | -1.65 Mn |